The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
HIF1α and HIF2α independently activate SRC to promote melanoma metastases
Open accessAbstract
Malignant melanoma is characterized by a propensity for early lymphatic and hematogenous spread. The hypoxia-inducible factor (HIF) family of transcription factors is upregulated in melanoma by key oncogenic drivers. HIFs promote the activation of genes involved in cancer initiation, progression, and metastases. Hypoxia has been shown to enhance the invasiveness and metastatic potential of tumor cells by regulating the genes involved in the breakdown of the ECM as well as genes that control motility and adhesion of tumor cells. Using a Pten-deficient, Braf-mutant genetically engineered mouse model of melanoma, we demonstrated that inactivation of HIF1α or HIF2α abrogates metastasis without affecting primary tumor formation. HIF1α and HIF2α drive melanoma invasion and invadopodia formation through PDGFRα and focal adhesion kinase-mediated (FAK-mediated) activation of SRC and by coordinating ECM degradation via MT1-MMP and MMP2 expression. These results establish the importance of HIFs in melanoma progression and demonstrate that HIF1α and HIF2α activate independent transcriptional programs that promote metastasis by coordinately regulating cell invasion and ECM remodeling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“whereas inactivation of HIF decreases the metastatic potential of tumor cells”
From Hypoxic control of metastasis (2016) · cites this paper as [47]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Safety, activity, and immune correlates of anti–PD-1 antibody in cancer
Topalian, S. L., Hodi, F. S., Brahmer, J. R., Gettinger, S. N., Smith, D. C., McDermott, D. F., Powderly, J. D., Carvajal, R. D., Sosman, J. A., Atkins, M. B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200690 · Cited by 12,628
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer
Brahmer, J. R., Tykodi, S. S., Chow, L. Q. M., Hwu, W.-J., Topalian, S. L., Hwu, P., Drake, C. G., Camacho, L. H., Kauh, J., Odunsi, K., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200694 · Cited by 7,945
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717 · cited 3×
“For example, HIF activates proangiogenic genes, such as VEGFA, PDGFB, and IL-8, genes that regulate cellular pH, such as carbonic anhydrase 9 (CA9), and genes that regulate glycolytic cellular metabolism, such as lactate dehydrogenase A (LDHA) and phosphofructokinase (PFK) (4, 5).”
BackgroundHypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177
Siegel, R. L., Ward, E., Brawley, O. W., & Jemal, A. (2011) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20121 · Cited by 4,075
Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway.
Kaelin, W. G., & Ratcliffe, P. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.04.009 · Cited by 3,251
A tense situation: forcing tumour progression
Butcher, D. T., Alliston, T. N., & Weaver, V. M. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2544 · Cited by 2,026
Nanomechanical analysis of cells from cancer patients
Cross, S. E., Jin, Y., Rao, J., & Gimzewski, J. K. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.388 · Cited by 1,906
HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression
Keith, B., Johnson, R. S., & Simon, M. C. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3183 · Cited by 1,693
Self-citationDifferential Roles of Hypoxia-Inducible Factor 1α (HIF-1α) and HIF-2α in Hypoxic Gene Regulation
Hu, C.-J., Wang, L.-Y., Chodosh, L. A., Keith, B., & Simon, M. C. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.24.9361-9374.2003 · Cited by 1,386
Self-citation
Research works printed but not linked: 1
- Blancher, 2001, Cancer Res., 61, 7349
Cited by
Sorted by citations
Items 101–147 of 147
Rauca, V. F., Pătraș, L., Lupuţ, L., Licărete, E., Toma, V. A., Porfire, A. S., Mot, A. C., Rákosy-Tican, E., Sesărman, A., & Banciu, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-01284-5 · Cited by 17
Zimmer, A. S., & Steeg, P. S. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1226-2 · Cited by 16
Harper, K., Brochu‐Gaudreau, K., Saucier, C., & Dubois, C. M. (2019) · Cancers · doi:10.3390/cancers11091403 · Cited by 16
Pucciarelli, D., Lengger, N., Takáčová, M., Csáderová, L., Bartošová, M., Breiteneder, H., Pastoreková, S., & Häfner, C. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3010 · Cited by 16
Advances in the Application of Nanomaterials to the Treatment of Melanoma
Wang, Z., Yu, Y., Wang, C., Li, J., & Pang, Y. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14102090 · Cited by 14
Bellazzo, A., Montico, B., Guerrieri, R., Colizzi, F., Steffan, A., Polesel, J., & Fratta, E. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02173-4 · Cited by 16
Wang, D., Li, M., Shen, H., Yang, J., Gao, Z., & Tang, Y. (2022) · Biological Trace Element Research · doi:10.1007/s12011-022-03296-2 · Cited by 13
Hypoxia-activated prodrug enhances therapeutic effect of sunitinib in melanoma
Liu, S., Tetzlaff, M. T., Wang, T., Chen, X., Yang, R., Kumar, S. M., Vultur, A., Li, P., Martin, J. S., Herlyn, M., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.22944 · Cited by 13
Potential Mutations in Uveal Melanoma Identified Using Targeted Next-Generation Sequencing
Yu, J., Wu, X., Yan, J., Yu, J., Yin, T., Dai, J., Ma, M., Xu, T., Yu, H., Xu, L., et al. (2019) · Journal of Cancer · doi:10.7150/jca.26967 · Cited by 13
HIF-1α, NOTCH1, ADAM12, and HB-EGF are overexpressed in mucoepidermoid carcinoma
Branco, D. C., da Costa, N. M. M., Abe, C. T. S., Kataoka, M. S. D. S., Pinheiro, J. D. J. V., & Júnior, S. D. M. A. (2018) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2018.09.013 · Cited by 12
Targeting aurora kinase A inhibits hypoxia-mediated neuroblastoma cell tumorigenesis.
Romain, C. V., Paul, P., Lee, S., Qiao, J., & Chung, D. H. (2014) · PubMed · Cited by 12
New basic approach to treat non‐small cell lung cancer based on RNA ‐interference
Makowiecki, C., Nolte, A., Sutaj, B., Keller, T., Avci‐Adali, M., Stoll, H., Schlensak, C., Wendel, H. P., & Walker, T. (2013) · Thoracic Cancer · doi:10.1111/1759-7714.12065 · Cited by 11
Branco‐Price, C., Evans, C. E., & Johnson, R. S. (2013) · Oncotarget · doi:10.18632/oncotarget.1461 · Cited by 12
Datta, K. K., Periasamy, P., Mohan, S. V., Ziegman, R., & Gowda, H. (2021) · Cancers · doi:10.3390/cancers13092175 · Cited by 12
Development of small molecule inhibitors of hypoxia-inducible factors for cancer therapy
Semenza, G. L. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100075 · Cited by 10
An Automated High-throughput Array Microscope for Cancer Cell Mechanics
Cribb, J., Osborne, L. D., Beicker, K. N., Psioda, M. A., Chen, J., O’Brien, E. T., Taylor, R. M., Vicci, L., Hsiao, J. P.-L., Shao, C., et al. (2016) · Scientific Reports · doi:10.1038/srep27371 · Cited by 11
Self-citationMicro RNAs Promoting Growth and Metastasis in Preclinical In Vivo Models of Subcutaneous Melanoma
Weidle, U. H., Ausländer, S., & Brinkmann, U. (2020) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20221 · Cited by 10
Increasing demonstration of angiogenic markers in skin neoplastic lesions
de Almeida, C. M., de Jesus, S. F., Poswar, F. D. O., Gomes, E. S. B., Fraga, C. A. D. C., Farias, L. C., Santos, S. H. S., Feltenberger, J. D., de Paula, A. M. B., & Guimarães, A. L. S. (2015) · Pathology - Research and Practice · doi:10.1016/j.prp.2015.12.004 · Cited by 8
Src and SCC : getting to the FAK s
Ainger, S. A., & Sturm, R. A. (2015) · Experimental Dermatology · doi:10.1111/exd.12725 · Cited by 8
Mitochondrial VHL rewires cell metabolism in hypoxia
Li, G., Pan, W., Wu, L., Cai, Z., Chen, H., Wu, X., Yu, T., Liao, K., Zhang, H., 温星桥, et al. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.11.013 · Cited by 10
Boss, M., Oberley‐Deegan, R. E., Batinic̈‐Haberle, I., Talmon, G. A., Somarelli, J. A., Xu, S., Kosmacek, E. A., Griess, B., Mir, S. U. R., Shrishrimal, S., et al. (2020) · Radiation Research · doi:10.1667/rade-20-00109.1 · Cited by 7
Chen, Q., Shi, R., Jiang, D., Liu, W., & Jia, Z. (2017) · PubMed Central · Cited by 7
He, Q., He, Y., Li, C., Wang, J., Xia, T., Xiong, X., Xu, J., & Liu, L. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-05425-3 · Cited by 6
The clinical landscape of HIF2α inhibitors in oncology
Saad, E., Machaalani, M., McDermott, D. F., & Choueiri, T. K. (2026) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-026-01145-y · Cited by 4
Zhang, X., Liu, Y., Liu, X., Tan, J., Yuan, L., Wu, W., Li, X., Xi, P., Li, G., & Song, Z. (2026) · APOPTOSIS · doi:10.1007/s10495-025-02218-6 · Cited by 4
Generation of metastatic melanoma specific antibodies by affinity purification
Schütz, B., Koppensteiner, A., Schörghofer, D., Kinslechner, K., Timelthaler, G., Eferl, R., Hengstschläger, M., Mißbichler, A., Hundsberger, H., & Mikula, M. (2016) · Scientific Reports · doi:10.1038/srep37253 · Cited by 4
Selective Inhibition of HIF1α Expression by ZnSO4 Has Antitumoral Effects in Human Melanoma
Burián, Z., Ladányi, A., Barbai, T., Piurkó, V., Garay, T., Rásó, E., & Tı́már, J. (2019) · Pathology & Oncology Research · doi:10.1007/s12253-018-00573-1 · Cited by 4
Ouyang, Y., Tang, J., Liu, Y., Chen, Y., Huo, Y., Peng, Z., Fang, Y., Yu, M., & Wu, M. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.164262 · Cited by 3
Habenicht, L., Hassan, N., Espinoza‐Sánchez, N. A., Onyeisi, J. O. S., Győrffy, B., Hanker, L., Greve, B., & Götte, M. (2025) · Cells · doi:10.3390/cells14201612 · Cited by 5
PARVB promotes malignant melanoma progression and is enhanced by hypoxic conditions
Wang, T., Wu, Z., Bi, Y., Wang, Y., Zhao, C., Sun, H., Wu, Z., Tan, Z. W., Zhang, H., Wei, H., et al. (2024) · Translational Oncology · doi:10.1016/j.tranon.2023.101861 · Cited by 3
Zhang, Z., Li, Q., Li, A., Wang, F., Li, Z., Meng, Y., & Zhang, Q. (2021) · Translational Andrology and Urology · doi:10.21037/tau-21-569 · Cited by 3
Unraveling the role of HIF2α in melanoma progression and epithelial–mesenchymal transition
Zhao, H. Q., Gao, Y., Li, Z., Liu, Z., Zhang, J., Jing, T., Xv, Y., Miao, G., Li, X., & Chen, A. (2025) · Scientific Reports · doi:10.1038/s41598-025-02384-2 · Cited by 2
Albrecht, M., Sciumè, G., Lucarelli, P., & Sauter, T. (2016) · IFAC-PapersOnLine · doi:10.1016/j.ifacol.2016.12.141 · Cited by 2
Retinoic acid aliphatic amide inhibits the AMPK-HIF-1α pathway in human ovarian cancer.
Yu, X., Xia, J., Ye, H., Li, X., Zhang, Y., & Mao, X. (2015) · Europe PMC (PubMed Central) · Cited by 2
Uncovering the Intricate and Heterogeneous Cellular Microenvironment of Cutaneous Melanoma
Țăpoi, D. A., Lambrescu, I. M., Manole, C. G., Gaina, G. F., & Ceafalan, L. C. (2026) · Medicina · doi:10.3390/medicina62040739 · Cited by 2
Manipulating the hypoxic tumour microenvironment to study therapy resistance
Ient, J. (2021) · Research Publications (Maastricht University) · doi:10.26481/dis.20210311jl · Cited by 1
Wang, T., Yun, S. J., & Xu, X. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3554-3_1
Bailey, S. T. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/nfxr-rg33
Self-citationCancer Stem Cells in Patient Survival and Therapies in Cancer
Yang, Y., Tian, C., & Meng, W. (2020) · Springer eBooks · doi:10.1007/978-981-15-5120-8_18
Mitochondrial metabolism and carcinogenesis
Aras, S., Purandare, N., & Grossman, L. I. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822416-8.00001-4
Wang, T., Wu, Z., Bi, Y., Sun, H., Wu, Z., Wang, Y., Yan, W., Wei, H., & Wang, C. (2020) · doi:10.21203/rs.3.rs-35978/v1
Deubiquitination of UTP14A stabilizes HIF-1α and promotes melanoma angiogenesisPreprint
Yu, Y., Lu, Q., Zhang, Y., & Jiang, G. (2023) · Research Square · doi:10.21203/rs.3.rs-3258063/v1
Long-term Hypoxia Inhibits Sphere Formation on PC-3 and MDA-MB-231 Cell Line Models
Akhunzianov, A. A., Filina, J. V., Zolotykh, M. A., Rizvanov, A. A., & Рифкатовна, М. Р. (2024) · The Open Biochemistry Journal · doi:10.2174/011874091x307243240513092933
Molecular Pathogenesis and Risk Factors for Cutaneous Melanoma
Almutairi, R., & AlBazali, A. A. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1011132
Jiao, Y., Ni, Y., Ge, L., Zhan, H., Xie, F., Hao, N., Xuan, L., Xia, H., Fang, Q., & Tao, Z. (2025) · Acta Tropica · doi:10.1016/j.actatropica.2025.107897
Additional file 1 of Computational models of melanoma
Albrecht, M., Lucarelli, P., Kulms, D., & Sauter, T. (2020) · Figshare · doi:10.6084/m9.figshare.12307859
Metadata
- Authors
- Hanna, S. C., Krishnan, B., Bailey, S. T., Moschos, S. J., Kuan, P.-F., Shimamura, T., Osborne, L. D., Siegel, M. B., Duncan, L. M., O’Brien, E. T., Superfine, R., Miller, C. R., Simon, M. C., Wong, K.-K., & Kim, W. Y.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Loyola University Chicago (US)
- Harvard University (US)
- University of Pennsylvania (US)
- Corresponding author
- Kim, William Y.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2013-04-08
- Volume
- 123
- Issue
- 5
- Pages
- 2078-2093
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3635738
- OpenAlex
- W2085551560
- Cited by
- 147
- References
- 41
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 5 · 2023: 4 · 2022: 6 · 2021: 11 · 2020: 16 · 2019: 13 · 2018: 11 · 2017: 16 · 2016: 13 · 2015: 15 · 2014: 21 · 2013: 5
- FWCI
- 6.32
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- UNC Libraries
- Funders
- U.S. Department of Defense (W81XWH, W81XWH0920042)
- Damon Runyon Cancer Research Foundation
- Melanoma Research Foundation
- Melanoma Research Alliance
- National Institutes of Health (5u54ca151652-05, NIH-R01, W81XWH)
- National Cancer Institute (R01CA166480, U54‐CA151652, CA120964, CA163896, CA141576, R01CA122794, R01CA140594, CA 140594, R33CA155618, CA 122794, R01CA142794, P01CA154303, R01CA163896, P50CA093683, P01CA120964, P30CA016086, U01CA141576, CA 166480)
- National Institute of General Medical Sciences (T32GM007092)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK034987)
- National Institute of Environmental Health Sciences (P30ES010126)
- Center for Gastrointestinal Biology and Disease, School of Medicine, University of North Carolina at Chapel Hill
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Keywords
- HIF-1α, HIF-2α, melanoma metastasis, Src kinase, hypoxia-inducible factor, tumor invasion, invadopodia, PDGFRA, focal adhesion kinase, extracellular matrix remodeling, MT1-MMP, MMP-2, tumor cell motility
- MeSH terms
- Endothelial PAS Domain-Containing Protein 1, Animals, Hypoxia, Extracellular Matrix, Humans, Melanoma, Microscopy, Fluorescence, Mutation, Neoplasm Metastasis, Oncogenes, Skin Neoplasms, Gene Expression Regulation, Neoplastic, RNA, Small Interfering, Cell Line, Tumor, Proto-Oncogene Proteins B-raf, PTEN Phosphohydrolase, Mice, Focal Adhesion Protein-Tyrosine Kinases, Basic Helix-Loop-Helix Proteins, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
